<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) is a <z:hpo ids='HP_0002664'>neoplasm</z:hpo> originating from germinal centre cells, corresponding to 25-40% of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Transformation into diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) occurs in about one-third of cases </plain></SENT>
<SENT sid="2" pm="."><plain>CD5 is expressed in B-<z:hpo ids='HP_0011010'>chronic</z:hpo> lymphoid <z:mpath ids='MPATH_336'>leukaemia</z:mpath>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, but can rarely be expressed in conjunction with CD10 in well-documented cases of FL </plain></SENT>
<SENT sid="3" pm="."><plain>In this report one case of grade 1 FL is described, which transformed into a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> 6 months after initial diagnosis, with both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> expressing CD5 </plain></SENT>
<SENT sid="4" pm="."><plain>In both specimens, neoplastic cells were strongly positive for CD20, CD79a, bcl-2, bcl-6 and CD5 in virtually <z:hpo ids='HP_0000001'>all</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>CD10 was strongly positive in initial specimens and weakly positive in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Investigation using the PCR confirmed the derivation of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> from the FL as they presented the same immunoglobulin heavy chain gene rearrangement and the same BCL2-J(H) break point </plain></SENT>
</text></document>